5.46 - 5.56
4.95 - 8.28
1.7K / 2.4K (Avg.)
-276.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.32%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
8.60%
Positive gross profit growth while HUH1V.HE is negative. John Neff would see a clear operational edge over the competitor.
69.00%
EBIT growth above 1.5x HUH1V.HE's 14.35%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
69.00%
Operating income growth above 1.5x HUH1V.HE's 14.35%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
36.42%
Net income growth above 1.5x HUH1V.HE's 13.90%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
20.00%
EPS growth 1.25-1.5x HUH1V.HE's 15.22%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
20.00%
Diluted EPS growth 1.25-1.5x HUH1V.HE's 15.22%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
13.68%
Share count expansion well above HUH1V.HE's 0.00%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
13.68%
Diluted share count expanding well above HUH1V.HE's 0.00%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
-10.71%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
35.62%
Positive FCF growth while HUH1V.HE is negative. John Neff would see a strong competitive edge in net cash generation.
-32.58%
Negative 10Y revenue/share CAGR while HUH1V.HE stands at 68.59%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-20.63%
Negative 5Y CAGR while HUH1V.HE stands at 33.04%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-1.38%
Negative 3Y CAGR while HUH1V.HE stands at 13.70%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
259.95%
Positive long-term OCF/share growth while HUH1V.HE is negative. John Neff would see a structural advantage in sustained cash generation.
117.57%
5Y OCF/share CAGR at 50-75% of HUH1V.HE's 169.67%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
190.16%
Positive 3Y OCF/share CAGR while HUH1V.HE is negative. John Neff might see a big short-term edge in operational efficiency.
0.00%
Below 50% of HUH1V.HE's 138.34%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-33.33%
Negative 5Y net income/share CAGR while HUH1V.HE is 83.47%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-40.00%
Negative 3Y CAGR while HUH1V.HE is 23.07%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
19.20%
Below 50% of HUH1V.HE's 82.82%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
24.65%
5Y equity/share CAGR at 50-75% of HUH1V.HE's 41.59%. Martin Whitman would question a shortfall in capital accumulation vs. the competitor.
18.48%
3Y equity/share CAGR 1.25-1.5x HUH1V.HE's 15.40%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
-100.00%
Cut dividends over 10 years while HUH1V.HE stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.35%
Firm’s AR is declining while HUH1V.HE shows 4.23%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-6.98%
Inventory is declining while HUH1V.HE stands at 9.26%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.79%
Negative asset growth while HUH1V.HE invests at 5.91%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-13.40%
We have a declining book value while HUH1V.HE shows 0.50%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.07%
We’re deleveraging while HUH1V.HE stands at 16.80%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Our R&D shrinks while HUH1V.HE invests at 10.42%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-14.50%
We cut SG&A while HUH1V.HE invests at 1.68%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.